Fig. 2.
Trial profile. For cohort 1 and cohort 2, the Nexvax2 starting dose was 30 μg; for cohort 1′ and cohort 2′, the Nexvax2 starting dose was 3 μg.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.